Canadian Sec - Delayed Quote CAD

IM Cannabis Corp. (IMCC.CN)

2.2000
-0.2500
(-10.20%)
At close: May 9 at 2:08:02 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
54,031
54,031
48,804
54,335
34,053
Cost of Revenue
45,580
45,580
38,958
45,173
27,720
Gross Profit
8,451
8,451
9,846
9,162
6,333
Operating Expense
18,685
18,685
22,021
31,665
29,368
Operating Income
-10,234
-10,234
-12,175
-22,503
-23,035
Net Non Operating Interest Income Expense
-2,560
-2,560
3,335
4,731
22,871
Other Income Expense
--
--
-617
-8,288
--
Pretax Income
-12,794
-12,794
-9,457
-26,060
-164
Tax Provision
-1,023
-1,023
771
-1,138
500
Net Income Common Stockholders
-10,585
-10,585
-9,498
-188,890
-17,763
Diluted NI Available to Com Stockholders
-10,585
-10,585
-9,498
-188,890
-17,763
Basic EPS
-4.51
--
-4.45
-157.83
-18.60
Diluted EPS
-4.51
--
-4.45
-161.88
-39.60
Basic Average Shares
2,349.2210
--
2,136.5490
1,196.8030
955
Diluted Average Shares
2,349.2210
--
2,136.5490
1,247.5270
955
Total Operating Income as Reported
-10,234
-10,234
-12,792
-30,791
-23,035
Total Expenses
64,265
64,265
60,979
76,838
57,088
Net Income from Continuing & Discontinued Operation
-10,585
-10,585
-9,498
-188,890
-17,763
Normalized Income
-10,585
-10,585
-9,022.9100
-14,584.9242
91
Interest Income
1,906
1,906
7,006
6,703
23,544
Interest Expense
4,466
4,466
3,671
1,972
673
Net Interest Income
-2,560
-2,560
3,335
4,731
22,871
EBIT
-8,328
-8,328
-5,786
-24,088
509
EBITDA
-6,144
-6,144
-2,790
-16,757
6,238
Reconciled Cost of Revenue
45,573
45,573
38,956
40,602
23,266
Reconciled Depreciation
2,184
2,184
2,996
7,331
5,729
Net Income from Continuing Operation Net Minority Interest
-10,585
-10,585
-9,498
-22,511
91
Total Unusual Items Excluding Goodwill
0
0
-617
-8,288
0
Total Unusual Items
0
0
-617
-8,288
0
Normalized EBITDA
-6,144
-6,144
-2,173
-8,469
6,238
Tax Rate for Calcs
0.0001
0.0001
0.0002
0
0.0002
Tax Effect of Unusual Items
0
0
-141.9100
-361.9242
0
12/31/2021 - 8/8/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AAWH-U.CN Ascend Wellness Holdings, Inc.
0.3800
-2.56%
 
NGQ1.F Medicure Inc.
0.5350
-0.93%
 
KABRADG.BO Kabra Drugs Limited
11.08
0.00%
 
002755.SZ Beijing Aosaikang Pharmaceutical Co., Ltd.
17.95
+1.41%
 
300723.SZ ApicHope Pharmaceutical Group Co., Ltd.
35.95
-1.53%
 
688506.SS Sichuan Biokin Pharmaceutical Co.,Ltd.
280.00
+0.61%
 
069620.KS Daewoong Pharmaceutical Co., Ltd
140,700.00
-1.40%
 
HLNl.XC
 
TRILC.IS Turk Ilac Ve Serum Sanayi Anonim Sirketi
19.49
-0.61%
 
MRMD.CN MariMed Inc.
0.1350
0.00%